242 related articles for article (PubMed ID: 35772926)
21. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
[TBL] [Abstract][Full Text] [Related]
22. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune gastritis: histology phenotype and OLGA staging.
Rugge M; Fassan M; Pizzi M; Zorzetto V; Maddalo G; Realdon S; De Bernard M; Betterle C; Cappellesso R; Pennelli G; de Boni M; Farinati F
Aliment Pharmacol Ther; 2012 Jun; 35(12):1460-6. PubMed ID: 22519568
[TBL] [Abstract][Full Text] [Related]
24. Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging.
Rugge M; Sugano K; Scarpignato C; Sacchi D; Oblitas WJ; Naccarato AG
Helicobacter; 2019 Apr; 24(2):e12571. PubMed ID: 30773732
[TBL] [Abstract][Full Text] [Related]
25. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.
Sato Y; Iwafuchi M; Ueki J; Yoshimura A; Mochizuki T; Motoyama H; Sugimura K; Honma T; Narisawa R; Ichida T; Asakura H; Van Thiel DH
Dig Dis Sci; 2002 Mar; 47(3):579-85. PubMed ID: 11911346
[TBL] [Abstract][Full Text] [Related]
26. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y
PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655
[TBL] [Abstract][Full Text] [Related]
27. Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System.
Bellolio E; Riquelme I; Riffo-Campos AL; Rueda C; Ferreccio C; Villaseca M; Brebi P; Muñoz S; Araya JC
Pathol Oncol Res; 2019 Jul; 25(3):1135-1142. PubMed ID: 30467699
[TBL] [Abstract][Full Text] [Related]
28. OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients.
Rugge M; Genta RM; Fassan M; Valentini E; Coati I; Guzzinati S; Savarino E; Zorzi M; Farinati F; Malfertheiner P
Am J Gastroenterol; 2018 Nov; 113(11):1621-1628. PubMed ID: 30333540
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis.
Petersson F; Borch K; Franzén LE
Scand J Gastroenterol; 2002 Mar; 37(3):262-6. PubMed ID: 11916187
[TBL] [Abstract][Full Text] [Related]
30. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.
Kapadia CR
J Clin Gastroenterol; 2003; 36(5 Suppl):S29-36; discussion S61-2. PubMed ID: 12702963
[TBL] [Abstract][Full Text] [Related]
31. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years.
Hwang YJ; Kim N; Lee HS; Lee JB; Choi YJ; Yoon H; Shin CM; Park YS; Lee DH
Aliment Pharmacol Ther; 2018 Feb; 47(3):380-390. PubMed ID: 29193217
[TBL] [Abstract][Full Text] [Related]
32. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.
Rugge M; Meggio A; Pravadelli C; Barbareschi M; Fassan M; Gentilini M; Zorzi M; Pretis G; Graham DY; Genta RM
Gut; 2019 Jan; 68(1):11-17. PubMed ID: 29306868
[TBL] [Abstract][Full Text] [Related]
33. Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis.
Fassan M; Saraggi D; Balsamo L; Cascione L; Castoro C; Coati I; De Bernard M; Farinati F; Guzzardo V; Valeri N; Zambon CF; Rugge M
Oncotarget; 2016 Jan; 7(4):4915-24. PubMed ID: 26701848
[TBL] [Abstract][Full Text] [Related]
34. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
Wang X; Zhang Q; Han F; Wu Y
Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
[No Abstract] [Full Text] [Related]
35. Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia.
Quach DT; Le HM; Hiyama T; Nguyen OT; Nguyen TS; Uemura N
Helicobacter; 2013 Apr; 18(2):151-7. PubMed ID: 23167960
[TBL] [Abstract][Full Text] [Related]
36. Histological Features of Gastric Mucosa Serologically Diagnosed as Gastric Atrophy without Helicobacter pylori Infection.
Okuno H; Suzuki S; Watanabe H; Kusano C; Ikehara H; Moriyama M; Gotoda T
Digestion; 2020; 101(2):217-226. PubMed ID: 30870847
[TBL] [Abstract][Full Text] [Related]
37. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.
Rugge M; Fassan M; Pizzi M; Farinati F; Sturniolo GC; Plebani M; Graham DY
World J Gastroenterol; 2011 Nov; 17(41):4596-601. PubMed ID: 22147965
[TBL] [Abstract][Full Text] [Related]
38. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.
Shah SC; Piazuelo MB; Kuipers EJ; Li D
Gastroenterology; 2021 Oct; 161(4):1325-1332.e7. PubMed ID: 34454714
[TBL] [Abstract][Full Text] [Related]
39. Atrophic gastritis in young children and adolescents.
Ricuarte O; Gutierrez O; Cardona H; Kim JG; Graham DY; El-Zimaity HM
J Clin Pathol; 2005 Nov; 58(11):1189-93. PubMed ID: 16254110
[TBL] [Abstract][Full Text] [Related]
40. A case of autoimmune gastritis with fundic gland polyp-like pseudopolyps presenting with nodular enterochromaffin-like cell hyperplasia.
Kotera T; Takemoto T; Kushima R; Haruma K
Clin J Gastroenterol; 2021 Feb; 14(1):98-102. PubMed ID: 33219490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
